Does ribavirin concentration determine treatment success of first-generation DAA-based chronic HCV therapy?
We established the therapeutic range for ribavirin in boceprevir- and telaprevir-based therapy that balances safety and efficacy.
Patients who require TV surgery either as an isolated or a combined procedure constitute a high-risk group. The long-term survival is poor. Tricuspid valve repair with a ring annuloplasty is associated with improved survival and a lower reoperation rate than that with a suture annuloplasty.